THERABITE JAW MOTION REHABILITATION SYSTEM, ADULT TH001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2013-10-22 for THERABITE JAW MOTION REHABILITATION SYSTEM, ADULT TH001 manufactured by Atos Medical Ab.

Event Text Entries

[3796101] During another complaint issue the patient mentioned that he had got a broken jaw presumably from using the therabite jaw rehabilitation system.
Patient Sequence No: 1, Text Type: D, B5


[11140874] The product is not available for investigation. Information provided by the customer is very limited and all efforts to obtain more information have failed. The upper mouthpiece has a design which purpose is to make it dislodge if the force is too high. This is to protect the patient from harm caused by too high exercising force. Tests have been performed to evaluate the mechanical strength of the therabite (tr-05-061). Amongst the samples tested the average strength was 356n and the sample with the highest mechanical strength was measured to 366n. According to studies (sathyanarayna, h. P. , premkumar, s,. 2012 and waltimo, a. , k? N? Nen, m. , 1993) the maximal bite force of healthy subjects are for women around 550-600n and for male 650-850n. This is at least ~200n above the force that would break the therabite, this means that the force to break the therabite would easily be reached by healthy individuals before any damage comes to the jaw. This strongly suggests that the patient has some kind of weakening of the jaw. In the ifu weakening of the jaw is a clear contraindication. Contraindications the therabite system should not be used by individuals who have or may have a fracture in the maxilla or mandible (upper or lower jaw) or other weaknesses of the bones of the jaw. Patients with infections of the jaw, osteomyelitis, or osteoradionecrosis of the jaw should not use the therabite system. Additionally in the warnings-section of the ifu patients are cautioned: injury may occur if excessive force is applied while using the therabite system, especially in users with weakened dentition, periodontal disease, weakened bones or joints, or gap-bridging plates. Users should disclose any such condition to their clinician before using the therabite system and should exercise extreme caution while using the product. Conclusion/action: the built in security feature in the mouth pieces secure that excessive force cannot be administered to the structures of the jaw. It can therefore be assumed that the patient has some type of condition that causes weakening of the jaw. In the ifu it is clearly contraindicated for patients with weakened jaw to use the device. No product malfunction. The patient has already been advised to stop using the device. Device not returned to manufacturer.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number8032044-2013-00007
MDR Report Key3421920
Report Source07
Date Received2013-10-22
Date of Report2013-10-22
Date Mfgr Received2013-09-23
Date Added to Maude2013-10-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR FERENC DAHNER
Manufacturer StreetPO-BOX 183
Manufacturer CityHORBY, SE-242 22
Manufacturer CountrySW
Manufacturer PostalSE-242 22
Manufacturer Phone415 19800
Manufacturer G1ATOS MEDICAL AB
Manufacturer StreetPO BOX 183
Manufacturer CityHORBY, SE-242 2
Manufacturer CountrySW
Manufacturer Postal CodeSE-242 22
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTHERABITE JAW MOTION REHABILITATION SYSTEM, ADULT
Generic NameJAW REHABILITATION TRAINER
Product CodeION
Date Received2013-10-22
Model NumberTH001
Catalog NumberTH001
Lot NumberUNKNOWN
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerATOS MEDICAL AB
Manufacturer AddressPO BOX 183 HORBY, SE-242 2 SW SE-242 22


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2013-10-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.